PZ Cormay S.A. (CRM.WA)
- Previous Close
0.5860 - Open
0.5760 - Bid 0.5740 x --
- Ask 0.5780 x --
- Day's Range
0.5700 - 0.5800 - 52 Week Range
0.3550 - 0.6300 - Volume
13,631 - Avg. Volume
75,295 - Market Cap (intraday)
48.67M - Beta (5Y Monthly) 0.88
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0700 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
PZ Cormay S.A. develops, manufactures, and sells diagnostic reagents in Poland. It offers testing products for clinical chemistry, electrophoresis, hematology, veterinary, coagulology, blood group serology, immunology, immunochemistry, molecular biology, sampling, oncological surgery, and general analytics, as well as vacuum blood collection system. The company offers its products under the Orphée and Diesse brand names. The company also exports its products to approximately 150 countries, including Germany, Austria, France, Greece, Turkey, Indonesia, Malaysia, England, China, Portugal, Czech Republic, Slovakia, Ukraine, Latvia, Bulgaria, and India. PZ Cormay S.A. was founded in 1985 and is based in Lomianki, Poland.
cormay.com225
Full Time Employees
December 31
Fiscal Year Ends
Sector
Scientific & Technical Instruments
Industry
Recent News: CRM.WA
View MorePerformance Overview: CRM.WA
Trailing total returns as of 5/2/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CRM.WA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CRM.WA
View MoreValuation Measures
Market Cap
48.67M
Enterprise Value
49.05M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.56
Price/Book (mrq)
0.98
Enterprise Value/Revenue
0.56
Enterprise Value/EBITDA
570.40
Financial Highlights
Profitability and Income Statement
Profit Margin
-7.25%
Return on Assets (ttm)
-3.65%
Return on Equity (ttm)
-11.78%
Revenue (ttm)
87.01M
Net Income Avi to Common (ttm)
-6.31M
Diluted EPS (ttm)
-0.0700
Balance Sheet and Cash Flow
Total Cash (mrq)
4.31M
Total Debt/Equity (mrq)
9.39%
Levered Free Cash Flow (ttm)
-123.75k